CompletedNot Applicable

A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne

United States40 participantsStarted 2023-05-31

Plain-language summary

The goal of this clinical trial is to compare Clear Skin Fomula Supplement to Placebo in healthy men and women ages 18-40 to mitigate mild to moderate non-cystic acne over the course of 12 weeks. Participants will be asked to take a daily supplement, have photos of their face taken and answer questionnaires related to their acne.

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy male or females of all Fitzpatrick Skin Types between 18 and 40 years of age.
✓. Subjects must be willing to provide verbal understanding and sign an Informed Consent Form, HIPAA Form and Photography Release Form approved by the Institutional Review Board.
✓. Subjects must be in general good health, as determined by the Investigator.
✓. Subjects must be willing and able to attend all study visits and comply with the test product daily instructions.
✓. Subjects must be willing to have VISIA facial photography imaging of their entire face for overall evaluation of their skin at all Visits.
✓. Subjects must be willing and able to complete and understand the various rating questionnaires.
✓. Subjects must have a Modifed IGA score of 2 (mild) or 3 (moderate) at the Baseline Visit.
✓. Subjects must have a facial non-cystic acne inflammatory lesion (papules and pustules) count with no less than 10 but no more than 50.

What they're measuring

Change in inflammatory lesion counts

Timeframe: Baseline to Day 84

Change in non-inflammatory lesion counts

Timeframe: Baseline to Day 84

Percentage/Proportion of subjects who achieve at least a one-grade reduction in the Modified IGA Score

Timeframe: Baseline to Day 84

Trial details

NCT IDNCT05879406

SponsorAblon Skin Institute Research Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-23

View on ClinicalTrials.gov More Non-Cystic Acne trials

Plain-language summary

Who can participate

Age range18 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Healthy male or females of all Fitzpatrick Skin Types between 18 and 40 years of age.
✓. Subjects must be willing to provide verbal understanding and sign an Informed Consent Form, HIPAA Form and Photography Release Form approved by the Institutional Review Board.
✓. Subjects must be in general good health, as determined by the Investigator.
✓. Subjects must be willing and able to attend all study visits and comply with the test product daily instructions.
✓. Subjects must be willing to have VISIA facial photography imaging of their entire face for overall evaluation of their skin at all Visits.
✓. Subjects must be willing and able to complete and understand the various rating questionnaires.
✓. Subjects must have a Modifed IGA score of 2 (mild) or 3 (moderate) at the Baseline Visit.
✓. Subjects must have a facial non-cystic acne inflammatory lesion (papules and pustules) count with no less than 10 but no more than 50.